Cardiac Toxicities Following Chimeric Antigen T-cell Therapy: A Post-Marketing Pharmacovigilance Analysis Using the FDA Adverse Event Reporting System

Transplantation and Cellular Therapy 2026

View at publisher

Authors: Malvika Gupta, Supriya Gupta, Christopher C. Graham

DOI: 10.1016/j.jtct.2025.12.673

Cited by: 0

Fields of Study & Subjects

Pharmacovigilance and Adverse Drug Reactions CAR-T cell therapy research Chemotherapy-induced cardiotoxicity and mitigation